Helmholtz Gemeinschaft


Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2021 | 2020 | 2019 | 2018 | 2015 | 2014 | 2012 | 2008 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993


Long-term effects of COVID-19 on kidney function.
Enghard, P. and Hardenberg, J.H. and Stockmann, H. and Hinze, C. and Eckardt, K.U. and Schmidt-Ott, K.M.
Lancet 397 (10287): 1806-1807. 15 May 2021

Novichok nerve agent poisoning.
Steindl, D. and Boehmerle, W. and Körner, R. and Praeger, D. and Haug, M. and Nee, J. and Schreiber, A. and Scheibe, F. and Demin, K. and Jacoby, P. and Tauber, R. and Hartwig, S. and Endres, M. and Eckardt, K.U.
Lancet 397 (10270): 249-252. 16 January 2021


Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Olivotto, I. and Oreziak, A. and Barriales-Villa, R. and Abraham, T.P. and Masri, A. and Garcia-Pavia, P. and Saberi, S. and Lakdawala, N.K. and Wheeler, M.T. and Owens, A. and Kubanek, M. and Wojakowski, W. and Jensen, M.K. and Gimeno-Blanes, J. and Afshar, K. and Myers, J. and Hegde, S.M. and Solomon, S.D. and Sehnert, A.J. and Zhang, D. and Li, W. and Bhattacharya, M. and Edelberg, J.M. and Waldman, C.B. and Lester, S.J. and Wang, A. and Ho, C.Y. and Jacoby, D.
Lancet 396 (10253): 759-769. 12 September 2020


Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Cree, B.A.C. and Bennett, J.L. and Kim, H.J. and Weinshenker, B.G. and Pittock, S.J. and Wingerchuk, D.M. and Fujihara, K. and Paul, F. and Cutter, G.R. and Marignier, R. and Green, A.J. and Aktas, O. and Hartung, H.P. and Lublin, F.D. and Drappa, J. and Barron, G. and Madani, S. and Ratchford, J.N. and She, D. and Cimbora, D. and Katz, E.
Lancet 394 (10206): 1352-1363. 12 October 2019

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz, S. and O'Connor, O.A. and Pro, B. and Illidge, T. and Fanale, M. and Advani, R. and Bartlett, N.L. and Christensen, J.H. and Morschhauser, F. and Domingo-Domenech, E. and Rossi, G. and Kim, W.S. and Feldman, T. and Lennard, A. and Belada, D. and Illés, A. and Tobinai, K. and Tsukasaki, K. and Yeh, S.P. and Shustov, A. and Hüttmann, A. and Savage, K.J. and Yuen, S. and Iyer, S. and Zinzani, P.L. and Hua, Z. and Little, M. and Rao, S. and Woolery, J. and Manley, T. and Trümper, L.
Lancet 393 (10168): 229-240. 19 January 2019


Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet 392 (10159): 1923-1994. 2018


Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer, K. and Goergen, H. and Hitz, F. and Zijlstra, J.M. and Greil, R. and Markova, J. and Sasse, S. and Fuchs, M. and Topp, M.S. and Soekler, M. and Mathas, S. and Meissner, J. and Wilhelm, M. and Koch, P. and Lindemann, H.W. and Schalk, E. and Semrau, R. and Kriz, J. and Vieler, T. and Bentz, M. and Lange, E. and Mahlberg, R. and Hassler, A. and Vogelhuber, M. and Hahn, D. and Mezger, J. and Krause, S.W. and Skoetz, N. and Böll, B. and von Tresckow, B. and Diehl, V. and Hallek, M. and Borchmann, P. and Stein, H. and Eich, H. and Engert, A.
Lancet 385 (9976): 1418-1427. 11 April 2015


Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
Libri, V. and Yandim, C. and Athanasopoulos, S. and Loyse, N. and Natisvili, T. and Law, P.P. and Chan, P.K. and Mohammad, T. and Mauri, M. and Tam, K.T. and Leiper, J. and Piper, S. and Ramesh, A. and Parkinson, M.H. and Huson, L. and Giunti, P. and Festenstein, R.
Lancet 384 (9942): 504-513. 9 August 2014


Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
Engert, A. and Haverkamp, H. and Kobe, C. and Markova, J. and Renner, C. and Ho, A. and Zijlstra, J. and Kral, Z. and Fuchs, M. and Hallek, M. and Kanz, L. and Doehner, H. and Doerken, B. and Engel, N. and Topp, M. and Klutmann, S. and Amthauer, H. and Bockisch, A. and Kluge, R. and Kratochwil, C. and Schober, O. and Greil, R. and Andreesen, R. and Kneba, M. and Pfreundschuh, M. and Stein, H. and Eich, H.T. and Mueller, R.P. and Dietlein, M. and Borchmann, P. and Diehl, V.
Lancet 379 (9828): 1791-1799. 12 May 2012


Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Nordlinger, B. and Sorbye, H. and Glimelius, B. and Poston, G.J. and Schlag, P.M. and Rougier, P. and Bechstein, W.O. and Primrose, J.N. and Walpole, E.T. and Finch-Jones, M. and Jaeck, D. and Mirza, D. and Parks, R.W. and Collette, L. and Praet, M. and Bethe, U. and Van Cutsem, E. and Scheithauer, W. and Gruenberger, T.
Lancet 371 (9617): 1007-1016. 22 March 2008


Arnold Graffi.
Stafford, N.
Lancet 367 : 980-980. 2006


Pseudo-pseudo Meigs' syndrome.
Schmitt, R. and Weichert, W. and Schneider, W. and Luft, F.C. and Kettritz, R.
Lancet 366 : 1672. 5 November 2005


Regenerative capacity of the myocardium: implications for treatment of heart failure.
von Harsdorf, R. and Poole-Wilson, P.A. and Dietz, R.
Lancet 363 : 1306-1313. 1 January 2004


Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
Kerr, D.J. and McArdle, C.S. and Ledermann, J. and Taylor, I. and Sherlock, D.J. and Schlag, P.M. and Buckels, J. and Mayer, D. and Cain, D. and Stephens, R.J.
Lancet 361 (1): 368-373. 1 February 2003

Gastric cancer.
Hohenberger, P. and Gretschel, S.
Lancet 362 : 305-315. 1 January 2003

Potential for sibutramine-yohimbine interaction? (correspondence).
Jordan, J. and Sharma, A.M.
Lancet 361 : 1826. 1 January 2003


Human pituitary growth hormone and cancer risk.
Kalra, P.R. and Genth-Zotz, S. and Coats, A.J.S. and Anker, S.D.
Lancet 360 (9347): 1791-1792. 30 November 2002

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
Cleland, J.G.F. and Cohen-Solal, A. and Aguilar, J.C. and Dietz, R. and Eastaugh, J. and Follath, F. and Freemantle, N. and Gavazzi, A. and van Gilst, W.H. and Hobbs, F.D.R. and Korewicki, J. and Madeira, H.C. and Preda, I. and Swedberg, K. and Widimsky, J.
Lancet 360 (9346): 1631-1639. 23 November 2002


Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes (Correspondence).
Stoerk, T. and Froehlich, E. and Moeckel, M.
Lancet 358 (9297): 1996-1997. 8 December 2001

Antisense therapy in oncology: new hope for an old idea?
Tamm, I. and Doerken, B. and Hartmann, G.
Lancet 358 (9280): 489-497. 11 August 2001

Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.
Jacobs, A. and Voges, J. and Reszka, R. and Lercher, M. and Gossmann, A. and Kracht, L. and Kaestle, C. and Wagner, R. and Wienhard, K. and Heiss, W.D.
Lancet 358 (9283): 727-729. 1 January 2001


The endotoxin-lipoprotein hypothesis.
Rauchhaus, M. and Coats, A.J.S. and Anker, S.D.
Lancet 356 (9233): 930-933. 9 September 2000

Regional hyperthermia for rectal cancer.
Hildebrandt, B. and Wust, P. and Rau, B. and Schlag, P.M. and Riess, H.
Lancet 356 (9231): 771-772. 26 August 2000

Association studies of genetic polymorphisms and complex disease.
Sharma, A.M.
Lancet 355 : 1277. 8 April 2000

Immunohistochemical detection of lymph-node metastases.
Bembenek, A. and Haensch, W. and Schneider, U. and Markwardt, J. and Schlag, P.M.
Lancet 355 : 144-145. 8 January 2000

Three-dimensional ultrasonography: new prospects for ultrasound imaging of bone.
Huenerbein, M. and Raschke, M. and Haas, N.P. and Schlag, P.M.
Lancet 355 (9198): 116-117. 8 January 2000


Coma in a park.
Pilz, B. and Mesner, C. and Baetgen, S. and Luft, F.C.
Lancet 354 : 1090. 25 September 1999

Endotoxins in chronic heart failure.
Brunkhorst, F.M.
Lancet 354 : 599-600. 14 August 1999

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Hjalmarson, A. and Goldstein, S. and Fagerberg, B. and Wedel, H. and Waagstein, F. and Kjekshus, J. and Wikstrand, J. and Hassle, A. and Westergren, G. and Hassle, A. and Thimell, M. and El Allaf, D. and Vitovec, J. and Aldershvile, J. and Halinen, M. and Dietz, R. and Neuhaus, K.L. and Janosi, A. and Thorgeirsson, G. and Dunselman, P. and Gullestad, L. and Kuch, J. and Herlitz, J. and Rickenbacher, P. and Ball, S. and Gottlieb, S. and Deedwania, P. and Vandenhoven, G. and Novakova, I. and Danker, S. and Lundstroem, M. and Meyer-Sabellek, W. and Balla, I. and Sveinsdottir, M. and Dorhout, B. and Hildebrandt, A. and Szczurko, I. and Larsson, C. and Bucher, E. and Scott, E. and Dwyer, D. and Julian, D.G. and DeMets, D.L. and Chatterjee, K. and Feyzi, J. and Lehto, S. and Karpati, P. and Motz, W. and Samuelsson, O. and Viersma, J.W. and Andersson, B. and Berthe, C. and Boutefeu, J.M. and Boxho, G. and Decroly, P. and Derbaudrenghien, J.P. and El Allaf, D. and Pirlet, J. and Henry, P. and Heyndrickx, G. and Missault, L. and Nannan, M. and Timmermans, P. and Vachiery, J.L. and Van Mieghem, W. and Vandenbossche, J.L. and Dvorak, K. and Herold, M. and Hradec, J. and Kana, A. and Petr, P. and Rybka, J. and Smid, J. and Svitil, P. and Toman, J. and Vitovec, J. and Agner, E. and Aldershvile, J. and Amtorp, O. and Egstrup, K. and Eliasen, P. and Gotzsche, C.O. and Hildebrandt, P. and Johannesen, A. and Kaiser-Nielsen, P. and Nielsen, H. and Nielsen, P.E. and Pedersen, F. and Nielsen, J.R. and Skagen, K. and Halinen, M. and Honkanen, T. and Hussi, E. and Juvonen, J. and Jaeaeskelaeinen, H. and Rinne, J. and Salonen, T. and Andresen, D. and Berwing, H. and Dietz, R. and Forster, A. and Hauf, G.F. and Krosse, B. and Luderitz, B. and von Olshausen, K.E. and Schmailzl, K.J.G. and Schwimmbeck, P.L. and Sigmund, M. and Voller, H. and Czuriga, I. and Hetey, M. and Janosi, A. and Katona, A. and Lengyel, M. and Nyaradi, A. and Rednik, A. and Sandori, K. and Szabo, P. and Tarjan, J. and Tenczer, J. and Timar, S. and Valyi, P. and Veress, G. and Zamolyi, K. and Oze, B. and Thorgeirsson, G. and Thorgeirsson, G. and Bernink, P.J.L.M. and Bredero, A.C. and Breedveld, R.W. and Breuls, P.N.W.M. and Bucx, J.J.J. and Cornel, J.H. and De Milliano, P.A.R. and Dunselman, P.H.J.M. and Hamer, B.J.B. and Holwerda, N.L. and Hoogsteen, J. and Hoorntje, J.C.A. and Kragten, J.A. and Liem, A.H. and Linssen, G.C.M. and Michels, H.R. and Misier, A.R.R. and Schaafsma, H.J. and Sijbring, P. and Taverne, R.J.T. and Van Kempen, L.H.J. and Van Stralen, R. and Van Veldhuisen, P.J. and Veerhoek, M.J. and Werter, C.J.P.J. and Wesdorp, J.C.L. and Willems, A.R. and Withagen, A.J.A.M. and Zwart, P.A.G. and Bjornerheim, R. and Dahle, M. and Dickstein, K. and Froland, G.S. and Gullestad, L. and Gundersen, T. and Hofsoy, K. and Hole, T.L. and Johansen, T. and Mannsverk, J. and Nesje, P. and Omland, T.M. and Sjodin, C. and Smith, P. and Tjonndal, H.A. and Vikesdal, O. and Waage, K. and Jaworska, K. and Kolodziej, P. and Kornacewicz-Jach, Z. and Krzeminska-Pakula, M. and Kuch, J. and Piotrowski, J.W. and Piwowarska, W. and Stogowski, A. and Wodniecki, J. and Wrabec, K. and Ahlstrom, P. and Ekdahl, S. and Hemmingson, L.O. and Herlitz, J. and Holmberg, L. and Lernfelt, B. and Nilsson, H. and Widgren, B. and Angman, K. and Erne, P. and Mohacsi, P. and Polikar, R. and Rickenbacher, P. and Schlapfer, H. and Batin, P. and Berkin, K.E. and Callaghan, T.S. and Forfar, J. and Frenneaux, M. and Greenbaum, R.A. and Maltz, M. and Murdoch, D. and Reynolds, G. and Stephens, J. and Struthers, A. and Swan, J. and Tildesley, G. and Abbasi, A. and Alagona, P. and Alderman, J. and Alipour, M. and Anderson, J.L. and Ansari, Z. and Ashraf, M. and Beanblossom, B.T. and Bennett, S. and Benvenuti, D. and Berk, M.R. and Bhalla, R. and Bilazarian, S.D. and Browne, K.F. and Buchter, C.M. and Carlson, R. and Carlson, C.J. and Danisa, K. and Dauber, I. and DeWood, M.A. and Deedwania, P. and Dennish, G. and Denny, D.M. and DiBianco, R. and Diller, P.M. and Dunlap, M. and Dowd, K. and Edmiston, A. and El Shahawy, M. and Elkayam, U. and Farnham, J. and Fenster, P. and Friedman, S. and Heywood, T. and Galichia, J.P. and Geller, M. and Ghali, J.K. and Gheorghiade, M.
Lancet 353 (9169): 2001-2007. 12 June 1999

Water drinking and the heart - Reply.
Jordan, J. and Shannon, J.R. and Robertson, D.
Lancet 353 (9168): 1971-1972. 5 June 1999

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.
Niebauer, J. and Volk, H.D. and Kemp, M. and Dominguez, M. and Schumann, R.R. and Rauchhaus, M. and Poole-Wilson, P.A. and Coats, A.J.S. and Anker, S.D.
Lancet 353 (9167): 1838-1842. 29 May 1999

A potent pressor response elicited by drinking water.
Jordan, J. and Shannon, J.R. and Grogan, E. and Biaggioni, I. and Robertson, D.
Lancet 353 (9154): 723. 27 February 1999

The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial.
Lechat, P. and Brunhuber, K.W. and Hofmann, R. and Osterziel, K.J.
Lancet 353 (9146): 9-13. 2 January 1999

Genetics and B-cell leukaemia.
Reis, A.
Lancet 353 : 3. 2 January 1999


Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
van Dongen, J.J. and Seriu, T. and Panzer-Gruemayer, E.R. and Biondi, A. and Pongers-Willemse, M.J. and Corral, L. and Stolz, F. and Schrappe, M. and Masera, G. and Kamps, W.A. and Gadner, H. and van Wering, E.R. and Ludwig, W.D. and Basso, G. and de Bruijn, M.A. and Cazzaniga, G. and Hettinger, K. and van der Does-van den Berg, A. and Hop, W.C. and Riehm, H. and Bartram, C.R.
Lancet 352 (9142): 1731-1738. 28 November 1998

Cutting edge of cardiomyopathy.
Poepping, I. and Thalhammer, C. and Pilz, B. and Luft, F.C.
Lancet 32 (9139): 1518-1518. 7 November 1998

Insulin-like growth factor-I and risk of breast cancer.
Strohm, O. and Osterziel, K.J. and Dietz, R.
Lancet 352 (9126): 489-489. 8 August 1998

Intraocular pressure and baroreflex failure.
Joos, K.M. and Kakaria, S.K. and Lai, K.S. and Shannon, J.R. and Jordan, J.
Lancet 351 (9117): 1704. 6 June 1998

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
Osterziel, K.J. and Strohm, O. and Schuler, J. and Friedrich, M. and Haenlein, D. and Willenbrock, R. and Anker, S.D. and Poole-Wilson, P.A. and Ranke, M.B. and Dietz, R.
Lancet 351 (9111): 1233-1237. 25 April 1998

Endothelial-cell permeability and protein kinase C in pre-eclampsia.
Haller, H. and Hempel, A. and Homuth, V. and Mandelkow, A. and Busjahn, A. and Maasch, C. and Drab, M. and Lindschau, C. and Juepner, A. and Vetter, K. and Dudenhausen, J. and Luft, F.C.
Lancet 351 (9107): 945-949. 28 March 1998

Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria.
Kun, J.F. and Mordmueller, B. and Lell, B. and Lehman, L.G. and Luckner, D. and Kremsner, P.G.
Lancet 351 (9098): 265-266. 24 January 1998


Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases.
Lakhani, S.R. and Easton, D.F. and Stratton, M.R. and Storferisser, A. and Anderson, T.J. and Farid, L.M. and Gusterson, B.A. and Jaquemier, J. and Sloane, J.P. and Venter, D. and Vandevijver, M.J. and Bishop, D.T. and Barkardottir, R.B. and Bignon, Y.J. and Cornelisse, C. and Changclaude, J. and Daly, P.A. and Devilee, P. and Egilsson, V. and Ford, D. and Goldgar, D. and Haites, N. and Hamann, U. and Klijn, J.G.M. and Lasset, C. and Lenoir, G. and Mcmanus, R. and Neuhausen, S. and Ormiston, W. and Ponder, B.A.J. and Peto, J. and Steel, C.M. and Stoppa-Lyonnet, D. and Smyth, E. and Sobol, H. and Spurr, N. and Scott, R.J. and Scherneck, S. and Streuwing, J.P. and Vasen, H. and Weber, B.
Lancet 349 : 1505-1510. 1 January 1997


Gestational diabetes.
Knoblauch, H. and Luft, F.C.
Lancet 347 (9003): 759-760. 16 March 1996


"Tumour suppressor gene" concept of carcinogenesis.
Wunderlich, V. and Rajewsky, M.F.
Lancet 345 (8964): 1570-1571. 17 June 1995

Safety of calcium antagonists.
Elliott, H.L. and Epstein, M. and Haller, H. and Mancia, G.
Lancet 346 (8987): 1421-1421. 1 January 1995

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
Finke, L.H. and Terpe, H.J. and Zorb, C. and Haensch, W. and Schlag, P.M.
Lancet 345 : 583-583. 1 January 1995


Functional autoimmune epitope on alpha1- adrenergic receptors in patients with malignant hypertension.
Fu, M.L.X. and Herlitz, H. and Wallukat, G. and Hilme, E. and Hedner, T. and Hoebeke, J. and Hjalmarson, A.
Lancet 344 (8938): 1660-1663. 17 December 1994

Posterior fossa neurovascular abnormalities in essential hypertension.
Naraghi, R. and Geiger, H. and Crnac, J. and Huk, W. and Fahlbusch, R. and Engels, G. and Luft, F.C.
Lancet 344 (8935): 1466-1470. 26 November 1994

Medical compared with surgical treatment for massive pulmonary embolism.
Gulba, D. and Schmid, C. and Borst, H.G. and Lichtlen, P.R. and Dietz, R. and Luft, F.C.
Lancet 343 (8897): 576-577. 5 March 1994

Familial adenomatous polyposis: mutation at codon 1309and early onset of colon cancer.
Caspari, R. and Friedl, W. and Mandl, M. and Moslein, G. and Kadmon, M. and Knapp, M. and Jacobasch, K.H. and Ecker, K. and Kreissler-Haag, D. and Timmermanns, G.
Lancet 343 (8898): 629-632. 1 January 1994


Environmental trichlorfon and cluster of congenital abnormalities.
Czeizel, A.E. and Elek, C. and Gundy, S. and Metneki, J. and Nemes, E. and Reis, A. and Sperling, K. and Timar, L. and Tusnady, G. and Viragh, Z.
Lancet 341 (8844): 539-542. 27 February 1993

Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants.
Baumann, I. and Testa, N.G. and Lange, C. and De Wynter, E. and Luft, T. and Dexter, T.M. and van Hoef, M.E. and Howell, A.
Lancet 341 (8841): 369. February 1993

Exclusion of the GABAA-receptor beta3 subunit gene as the Angelman's syndrome gene.
Reis, A. and Kunze, J. and Ladanyi, L. and Enders, H. and Klein-Vogler, U. and Niemann, G.
Lancet 341 (8837): 122-123. 9 January 1993

Isoenzyme BB of glycogen phosphorylase b and myocardial infarction.
Rabitzsch, G. and Mair, J. and Lechleitner, P. and Noll, F. and Hofmann, U. and Krause, E.G. and Dienstl, F. and Puschendorf, B.
Lancet 341 : 1032-1033. 1 January 1993

This list was generated on Sat Jun 19 02:25:47 2021 CEST.
Open Access
MDC Library